HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 46 filers reported holding HARPOON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $759 | -51.3% | 1,070 | -49.0% | 0.00% | – |
| Q1 2023 | $1,560 | – | 2,098 | +37.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,531 | +124.5% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 682 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 682 | -24.1% | 0.00% | – |
| Q1 2022 | $3,000 | -40.0% | 899 | +40.2% | 0.00% | – |
| Q4 2021 | $5,000 | -61.5% | 641 | -14.5% | 0.00% | – |
| Q3 2020 | $13,000 | +8.3% | 750 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |